mTOR: Role in cancer, metastasis and drug resistance

Cited by (485)

Items 301–400 of 485

1. Kelch-like protein 14 promotes proliferation and migration of ovarian cancer cells.
   Zhen Chen, Miaoxing Wu, Jiahua Liu · 2020 · Europe PMC (PubMed Central)
2. CMBs carrying PTX and CRISPR/Cas9 targeting C‑erbB‑2 plasmids interfere with endometrial cancer cells
   Siyuan Peng, Junhong Cai, Shan Bao · 2021 · Molecular Medicine Reports
3. Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells
   Huarui Cai, Zhongze Wang, Wenhan Tang, Xiaoxue Ke, Erhu Zhao · 2022 · Frontiers in Genetics
4. [Progress of NRF2 Signaling Pathway in Promoting Proliferation of Non-small Cell Lung Cancer].
   Yixuan Fang, Xinru Zou, Shuning Hu, Lili Ji · 2022 · PubMed Central
5. Dna Hypomethylation And Upregulated LINC00518 Acts As A Promoter And Biomarker In Head And Neck Squamous Cell Carcinoma
   Xueqin Wang, Jinquan Shen, Laifa Wang, Ling Deng, Hao Bo, Yanwei Luo, Yanhui Cui · 2023 · Epigenomics
6. Activated mTORC1 signaling pathway aggravates cisplatin induced oxidative damage by inhibiting autophagy in mouse cochlear hair cells
   Nana Xu, Yin-Chuan Wen, Jing Pan, Fan Shu, Jiaxi Qu, Xiaofei Qi, Jie Tang · 2025 · Neuropharmacology
7. Investigating the prognostic value of mTORC1 signaling in bladder cancer via bioinformatics evaluation
   Xin Yu, Wenge Li, Shengrong Sun, Juanjuan Li · 2023 · Scientific Reports
8. A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma
   Mingze Guan, Hua Zhao, Qi Zhang, Li Li, Xiaobo Wang, Bo Tang · 2024 · Expert Review of Molecular Diagnostics
9. ACE Loss Drives Renal Cell Carcinoma Growth and Invasion by Modulating AKT-FOXO1
   Lei Yin, Lixin Mao, Rui Yin, Chengxun Lv, Xiaokai Shi, Chuang Yue, Yin Chen, Chao Tsang Lu, Zonglin Wu, Kai Xu et al. · 2024 · Biologics
10. Substituents introduction of methyl and methoxy functional groups on resveratrol stabilizes mTOR binding for autophagic cell death induction
    Zin Zin, Satapat Racha, Preedakorn Chunhacha, Masashi Yokoya, Sohsuke Moriue, Hongbin Zou, Pithi Chanvorachote B · 2025 · Scientific Reports
11. Effect of rapamycin treatment in human seminoma TCam-2 cells through inhibition of G1-S transition
    Tuğçe Önel, Cihan Süleyman Erdogan, Başak Aru, Ecem Yıldırım, Gülderen Yanıkkaya Demirel, Aylin Yaba · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
12. Circular RNA circDLG1 (has_circ_0068706) functions as an oncogene in nonsmall cell lung cancer through regulating AKT / mTOR signaling and direct binding to miR ‐144
    Yongfeng Chen, Ai‐Ping Xu · 2023 · The Kaohsiung Journal of Medical Sciences
13. Sertindole inhibits autophagic flux and glioma progression
    Baiyang Liu, Yulin Shi, Bo Qin, Dating Cheng, Zhi Nie, Haoqing Zhai, Li Yao, Zhixian Jin, Jun Pu, Dongming Yan et al. · 2023 · MedComm – Oncology
14. Ginsenoside Rg1 inhibits multiple myeloma and overcomes bortezomib resistance through AMPK-mTOR pathway
    Li Lin, Dong Chen, Shuangyue Li, Tiantian Wang · 2024 · Heliyon
15. Recent progress of protein kinase inhibitors derived from marine peptides for developing anticancer agents
    Lanhong Zheng, Ning Wei, Ammad Ahmad Farooqı, Yan Zhang, Renald A. Blundell, Xiujun Liu, Yixin Xu, Xiukun Lin · 2024 · Cellular Signalling
16. A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules
    Amir R. Afshari, Mehdi Sanati, Samaneh Aminyavari, Zakieh Keshavarzi, Seyed Sajad Ahmadi, Fatemeh Oroojalian, Sercan Karav, Amirhossein Sahebkar · 2025 · Inflammopharmacology
17. Synergistic anti-cancer effects of metformin and cisplatin on YD-9 oral squamous carcinoma cells via AMPK pathway
    Paras Man PRADHAN, Young‐Hee Lee, Sungil Jang, Ho‐Keun Yi · 2025 · Journal of Applied Oral Science
18. Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
    Wangxia Tong, Na Qin, Tao Lu, Li Liu, Rong Liu, Jibing Chen, Ning Luo · 2025 · PLoS ONE
19. CHML is an NRF2 target gene that regulates mTOR function
    Matthew B. Dodson, Wujing Dai, Annadurai Anandhan, Cody J. Schmidlin, Pengfei Liu, Nathan C. Wilson, Yongyi Wei, Naoya Kitamura, James J. Galligan, Aikseng Ooi et al. · 2022 · Molecular Oncology
20. Photosensitizing metal–organic framework nanoparticles combined with tumor-sensitization strategies can enhance the phototherapeutic effect upon medullary thyroid carcinoma
    Yingqi Feng, Qiyu Jiang, Xue Ma, Huiwei Sun, Yantao Chai, Xiaojuan Li, Zhijie Wang, Fan Feng · 2024 · Biochimica et Biophysica Acta (BBA) - General Subjects
21. Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma
    Yi Zhang, Yuzhi Wang, Jiamiao Weng, Jianlin Chen, Yue Zheng, Yu Xia, Zhixin L. Huang, Lilan Zhao, Xiongfeng Chen, Haijun Tang et al. · 2024 · Molecular Carcinogenesis
22. Small-molecule mTOR inhibitors in the clinic: From bench to bedside
    Yang Chen, Xiaofei Sun, Zhong Yu, Dan Liu, Rong Hu · 2025 · Bioorganic Chemistry
23. Jervine-induced suppression of triple-negative breast cancer (TNBC) cells growth through the regulation of Wnt signaling pathway- an in-silico and in-vitro approach
    Anupriya Eswaran, Sathan Raj Natarajan, Selvaraj Jayaraman, Javed Masood Khan, Sharmila Jasmine, Vishnu Priya Veeraraghavan · 2026 · Journal of Computer-Aided Molecular Design
24. Development and validation of a vesicle-mediated transport-associated gene signature for predicting prognosis and immune therapy response in hepatocellular carcinoma
    Zhi-yang Liu, Yihe Li, Bowen Li, Xin Lin · 2023 · Journal of Cancer Research and Clinical Oncology
25. SLL-1A-16 suppresses proliferation and induces autophagy in non-small-cell lung cancer cells via the AKT/mTOR signaling pathway
    Xiaoqin Luo, Jin Wang, Ruichang Wang, Jiabing Lian, Mengnan Guo, Hongrui Zhou, Mengxue Zhang, Zhe Yang, Xiaolong Li, Xianran He et al. · 2024 · RSC Medicinal Chemistry
26. Succinylation modification-mediated upregulation of Sp1 promotes hepatocellular carcinoma cell proliferation
    Yehong Han, Xueqin Deng, Hạixia Chen, Jie Chen, Wei Xu, Lanqin Liu · 2024 · Discover Oncology
27. Cabergoline-induced NDFIP1 upregulation in pituitary neuroendocrine tumor cells activates mTOR signaling and contributes to cabergoline resistance
    Weiting Gu, Weifeng Zhang, Zhe Bao Wu, Yu Cai · 2025 · Journal of Neuro-Oncology
28. Role of PI3K/Akt/GSK-3 Pathway in Emesis and Potential New Antiemetics
    Zhong W, Darmani NA · 2020 · Journal of Cellular Signaling
29. High incidence of PI3K pathway gene mutations in South Indian cervical cancers
    Mathew Maria Rose, Shankar Dhamodharan, Sundaramoorthy Revathidevi, Sundaram Reddy Chakkarappan, Mani G Jagadeesan, Subbiah Shanmugam, Hirofumi Nakaoka, Ituro Inoue, Avaniyapuram Kannan Murugan, Arasambattu Kannan Munirajan · 2022 · Cancer Genetics
30. In silico repurposing of midostaurin as a therapeutic candidate for head and neck cancer via targeting SPARC/MMP9/CD44 Cancer-Associated Fibroblasts (CAFs) oncogenic signature.
    Kuan‐Chou Lin, Chia‐Che Wu, Ntlotlang Mokgautsi, Bashir Lawal, Ching‐Zong Wu, Alexander T.H. Wu, Yung‐Kang Shen, Ming-Che James Liu · 2023 · PubMed Central
31. AF9 targets acetyl-modified STAT6 to diminish purine metabolism and accelerate cell apoptosis during metastasis
    Jialiang Shao, Tiezhu Shi, Lianheng Chen, Xiang Wang, Hua Tao Yu, Ninghan Feng, Xiongjun Wang · 2023 · Cell Death and Differentiation
32. Roles of Rictor alterations in gastrointestinal tumors (Review)
    Ruizhen Cao, Shuilong Guo, Li Min, Peng Li · 2024 · Oncology Reports
33. Oncogenic MTOR Signaling Axis Compensates BTK Inhibition in a Chronic Lymphocytic Leukemia Patient with Richter Transformation: A Case Report and Review of the Literature
    Thomas Parigger, Stephan Drothler, Christian Scherhäufl, Franz Josef Gassner, Maria Schubert, Markus J. Steiner, Jan Philip Höpner, Alexandra Hödlmoser, Lena Schultheis, Aryunni Abu Bakar et al. · 2024 · Acta Haematologica
34. Comparison of mTOR inhibitors combined with endocrine therapy versus that alone in breast cancer: a meta-analysis
    Wei Zhang, Xinru Jia, Dandi Lou, Qingping Wu, Yici Yan, Feiyan Mao · 2025 · Future Oncology
35. The hipotises of the immune system's role in carcinogenesis
    Y. K Slepov, M. A. Laushkin, Roman V. Deev · 2021 · Genes and Cells
36. Adhesion molecule L1 inhibition increases infarct size in cerebral ischemia-reperfusion without change in blood-brain barrier disruption
    OAK ZA CHI, Thomas Theis, Suneel Kumar, Antonio Chiricolo, Xia Liu, Saad Farooq, Nishta Trivedi, Wise Young, Melitta Schachner, Harvey R. Weiss · 2021 · Neurological Research
37. Lawsone inhibits the proliferation and metastasis of residual breast cancer cells after microwave ablation by inducing cellular inhibitory autophagy through NCAPG/AURKB/AKT/mTOR axis
    Feixiang Sun, Ying Tong, Chuanpeng Zhang, Susu Yang, Yitao Liu, Jie Ji, Ziyi Yu, Yi Zhao · 2023 · Research Square
38. Deciphering the effects of PYCR family on cell function, prognostic value, immune infiltration in ccRCC and pan-cancer
    Hongquan Chen, Qing Chen, Jinyang Chen, Yazhen Mao, Lidi Duan, Dongjie Ye, Wenxiu Cheng, Jiaxi Chen, Xinrong Gao, Renxi Lin et al. · 2024 · Research Square
39. Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer
    Huixia Lu, Hong Hu, Zhihong Yang, Shaobo Li · 2023 · Medicine
40. Isoliquiritigenin Induces Apoptosis via ROS-Mediated Inhibition of p38/mTOR/STAT3 Pathway in Human Melanoma Cells
    Mi Jeong Kwon, Pawan Kumar Raut, Jeong‐Hoon Jang, Kyung‐Soo Chun · 2025 · Biomolecules & Therapeutics
41. USP5 Promotes Head and Neck Squamous Cell Carcinoma Progression via mTOR Signaling Pathway
    Ni Xiong, Yue Wang, Junhong Jiang · 2025 · Cancer Medicine
42. Tanshinone IIA ameliorates septic immunosuppression by balancing the Th17/Treg cell ratio and modulating Treg function after induction of autophagy
    Hao Ou, Bei Sun, Yu Jiang, Min Gao · 2025 · Archives of Biochemistry and Biophysics
43. LC-HRMS metabolomics, isolation, network pharmacology, and molecular docking based evaluation of anti-cancer potential of compounds of Glycyrrhiza glabra L.
    Sanheeta Chakrabarty, Hitesh Harsukhbhai Chandpa, Nancy Tripathi, Sagar Singh Shyamal, Anindita Bhattacharjee, Sanjay Kumar, Bharat Goel, Sanju Kumari, Jairam Meena, V. Ramanathan et al. · 2025 · Pharmacological Research - Natural Products
44. Engineering glutamine-regulating nanomedicines for efficient tumor therapy
    Guanghui Hou, Shunyi Lu, Youdong Chen, Huali Lei, Bin Yi, Liang Cheng · 2025 · Materials Today
45. Glutamine synthetase modulates YAP activation by stabilizing LATS under glutamine homeostasis
    Siyi Li, Ting Ling, Yuhan Wang, Jing Shi, Qiuping Wang, Jing Lv, Jinghan Li, Yu Liu, Yi Zhang, Changhao Liu et al. · 2025 · Cell Reports
46. mTOR-Dependent Autophagy Machinery Is Inhibited in Fibroblasts of Keloid
    Meng Jiang, Wenbo Bu, Yu-Jie Chen, Li Li, Ta Xiao, Heng Gu · 2021 · International Journal of Dermatology and Venereology
47. Sestrin2 Overexpression Ameliorates Endoplasmic Reticulum Stress-Induced Apoptosis via Inhibiting mTOR Pathway in HepG2 Cells
    Huiling Hu, Zhijun Luo, Xiuli Liu, Lisi Huang, Xiaoxia Lu, Rui Ding, Chaohui Duan, Yuqing He · 2022 · International Journal of Endocrinology
48. Investigation of Macrocyclic mTOR Modulators of Rapamycin Binding Site via Pharmacoinformatics Approaches
    Shraddha Parate, Vikas Kumar, Jong Chan Hong, Keun Woo Lee · 2023 · Computational Biology and Chemistry
49. PI3K Signaling Pathways as a Molecular Target for Glioblastoma Multiforme
    Andressa Letícia Lopes da Silva, Thiago Pina Goes de Araújo, Shakira Cavalcante de Albuquerque Ferreira, Anderson Brandão Leite, João Kaycke Sarmento da Silva, Lilyana Waleska Nunes Albuquerque, Ana Rachel Vasconcelos de Lima, Herbert Charles Silva Barros, Leandro Rocha Silva, Edeildo Ferreira da Silva‐Júnior et al. · 2023 · Current Protein and Peptide Science
50. Hematological and Neurological Expressed 1 Promotes Tumor Progression Through mTOR Signaling in Ovarian Cancer
    Pin Li, Li-Heng Qian, Ying-Na Liao, Yan-Zhi Gai, Hong Pan, Long Han, Hui Nie · 2024 · Reproductive Sciences
51. Importance of targeting various cell signaling pathways in solid cancers
    Chandrayee Ghosh, Jiangnan Hu · 2024 · International review of cytology
52. Identification of breast cancer-associated PIK3CA H1047R mutation in blood circulation using an asymmetric PCR assay
    Đinh Thị Thảo, Nguyen Phu Thanh, Đồng Văn Quyền, Ly Tuan Khai, Song Huu Le, Ngo Tat Trung · 2024 · PLoS ONE
53. Patient characteristics and evaluations prior to liver transplantation
    Maen Abdelrahim, Ali Jaber Alqahtani, Abdullah Esmail, Bandar Al‐Judaibi · 2024 · Elsevier eBooks
54. Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progression
    Dániel Sztankovics, Fatime Szalai, Dorottya Moldvai, Titanilla Dankó, Noémi Nagy, Judit Pápay, András Khoór, Ildikó Krencz, Anna Réka Sebestyén · 2024 · European Journal of Cell Biology
55. Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications
    Mehrdad Hashemi, Asal Abolghasemi Fard, Bita Pakshad, Pezhman Shafiei Asheghabadi, Amineh Hosseinkhani, Atena Sadat Hosseini, Parham Moradi, Mohammadreza Mohammadbeygi Niye, Ghazal Najafi, Mohadeseh Farahzadi et al. · 2024 · Non-coding RNA Research
56. Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas
    Avaniyapuram Kannan Murugan, Siddarth Kannan, Ali Saeed Alzahrani · 2025 · Current Problems in Cancer
57. M‐Phase Phosphoprotein 9 upregulation associates with poor prognosis and activates mTOR signaling in gastric cancer
    Lingling Xu, Yu Shang, Xiaona Qu, Hongmei He · 2020 · The Kaohsiung Journal of Medical Sciences
58. [Retracted] Establishment and Validation of an MTORC1 Signaling‐Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma
    Yao Zheng, Song Wen, Jun Peng Luo, Weiyuan Hao, Weiren Liang, Yutang Chen · 2021 · BioMed Research International · Retracted
59. PinX1-Promoted Autophagy Inhibits Cell Proliferation and Induces Cell Apoptosis by Inhibiting the NF-κB/p65 Signaling Pathway in Nasopharyngeal Carcinoma
    Mengxue Yang, Fang Chen, Chaosheng Yu, Zhimou Cai, Qingwen Zhong, Jialian Feng, Guanxue Li, Congxiang Shen, Zhong Wen · 2023 · Frontiers in Bioscience-Landmark
60. Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development
    Dashuai Yang, Ying Hu, Junfa Yang, Liangsong Tao, Yue Su, Yincui Wu, Yan Yao, Shuxian Wang, Sheng Ye, Tao Xu · 2024 · Journal of Pharmacology and Experimental Therapeutics
61. mTOR and AMP-Activated Protein Kinase in Obesity and Cancer
    Indranil Biswas, Shashank Kumar Maurya, Sabyasachi Senapati · 2021 · Springer eBooks
62. ɑ-Solanine Affects the Apoptosis and Angiogenesis of M2-Like TAMs Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway Under Hypoxia
    Jia-Yong Huang, Xiaowu Wang, Luo-Feng Pan, Minjie Jiang, Si-Yun Zhou, Haoyun Zhou, Hanzhang Fu, Binbo Fang · 2023 · Natural Product Communications
63. A Comprehensive Analysis of LYAR in Colorectal Cancer: Prognostic Marker and Therapeutic Target
    Jiaying Wen, Ye‐Ying Fang, Dongming Li, Yu-Lu Tang, Heqing Huang, Limin Liu, Jiang‐Hui Zeng, Yi‐Wu Dang, Yan-Fang Pan, Da-Tong Zeng et al. · 2024 · Cancer Biotherapy and Radiopharmaceuticals
64. p62: Intersection of Antioxidant Defense and Autophagy Pathways
    Gregory A. Shilovsky · 2024 · Molecular Biology
65. 1.25(OH)2D3 decreases PCNA and mTOR expression and alleviates renal injury in Thy-1 nephritis rat model
    LI Jian-feng, Lei Jin, Huan Ma, Jie Suo, Rui Yang, Xiao-Ping Yang · 2024 · PLoS ONE
66. FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways
    Qing Li, Yan Li, Tong Zhou, Yong Zhang, Huiyu Li, Fajia Yuan, Yanghui Bi · 2025 · PLoS ONE
67. The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer growth
    Zhengwei Yan, Luling He, Jiawei Yuan, Yulong Niu, Shimin Shuai, Shiwen Luo, Changzheng Du, Hai Rao · 2025 · Oncogene
68. Astrocytes from lamina cribrosa are involved in the autoregulatory function of optic nerve head vessels in vitro
    Xiaoxiao Feng, Wenjia Zhang, Tingting Wan, Kangwei Jiao, Liwei Zhang, Changhui Li, Libo Xiao · 2025 · Frontiers in Molecular Biosciences
69. RCN1 Binds KIF14 and Promotes the Malignant Growth of Cervical Cancer Through the PI3K-AKT Pathway
    Yanyu Li, Li Cai, Jiayun Zhou, Xuping Zhang, Yunuo Zheng, Jingbo Zhang, Hui Wen Cheng, Qing Wang, Bei Zhang · 2025 · International Journal of General Medicine
70. Breaking the Calcium Overload Cycle in Acute Pancreatitis: Emerging Pharmacological Strategies
    Serge Chooklin, S.S. Chuklin · 2026 · Digestive Diseases and Sciences
71. MTFR2 promotes VDAC1 oligomerization to reprogram BCAA metabolism in tumor cells to polarize TAMs in LUAD
    Yutong Ge, Tao Yu, Shaokun Yu, Ao Sun, Shiyu Zhang, Meiling Zhang, Qian Wang, Jia Liu, Xuan Zhang, Lulin Zeng et al. · 2026 · Cell Death and Disease
72. mTORC2 Phosphorylation of GSDME‐N Drives Cullin4B‐Mediated Proteasomal Degradation to Suppress Pyroptosis and Confer Radioresistance in Small Cell Lung Cancer
    Qingqing Xu, Ci-ming Sun, Sui-xian Zhang, R Li, Chen‐Fei Wu, Z T Lin, Li Li, Run‐zhe Chen, Qi-Wen Li, Yuanyuan Chen et al. · 2026 · Advanced Science
73. Aggressive advanced gastric cancer in a patient with autosomal dominant polycystic kidney disease
    Takeshi Yasuda, Takeshi Ishikawa, Ryohei Hirose, Toshifumi Doi, Ken Inoue, Osamu Dohi, Naohisa Yoshida, Kazuhiro Kamada, Kazuhiko Uchiyama, Tomohisa Takagi et al. · 2021 · Clinical Journal of Gastroenterology
74. mTOR inhibitors in a patient with lupus nephritis; why not?
    Raquel Berzal, Beatriz Agredano Ávila, Marco Gil, María Galindo-Izquierdo, Enrique Morales · 2022 · Nefrología
75. [Numb activates the mTORC1 signaling pathway in proximal tubular epithelial cells by upregulating V1G1 expression].
    Z Liu, Da You, Y Li, Yongmei He, and Naishi Li, P Li, C Li · 2022 · PubMed Central
76. mTOR inhibitors in a patient with lupus nephritis; why not?
    Raquel Berzal, Beatriz Agredano Ávila, Marco Gil, María Galindo-Izquierdo, Enrique Morales · 2022 · Nefrología (English Edition)
77. Orchestrating Cellular Balance: ncRNAs and RNA Interactions at the Dominant of Autophagy Regulation in Cancer
    Xueni Yang, Shizheng Xiong, Xinmiao Zhao, Jiaming Jin, Xinbing Yang, Yajing Du, Linjie Zhao, Zhiheng He, Chengjun Gong, Li Guo et al. · 2024 · International Journal of Molecular Sciences
78. TIPRL, a Potential Double-edge Molecule to be Targeted and Re-targeted Toward Cancer
    Jie Gao, Tiantian You, Jiao Liu, Lili Yang, Yan Liu, Yanyan Wang · 2024 · Cell Biochemistry and Biophysics
79. Development and validation of a nomogram model based on blood-based genomic mutation signature for predicting the risk of brain metastases in non-small cell lung cancer
    Jiabin Fang, Lina Chen, Shuyao Pan, Qing Li, Siqiang Liu, Sufang Chen, Xiaojie Yang, Qiongyao Zhang, Yusheng Chen, Hongru Li · 2024 · BMC Pulmonary Medicine
80. The effect and mechanism of atorvastatin regulating PI3K-Akt–mTOR pathway on radiosensitivity of hepatocellular carcinoma cells
    Zhengzheng Deng, Jinjing Guo, Zihao Zhu, Qiancheng Qing, Dangting Wan, Pengyuan Lei, Qi Liu, Bo Huang · 2024 · Toxicology Research
81. LINC00622 transcriptionally promotes RRAGD to repress mTORC1-modulated autophagic cell death by associating with BTF3 in cutaneous melanoma
    Can Li, Ke Wang, Lei Zhao, Jieyu Liu, Yi Jin, Chun‐Ting Zhang, Minna Xu, Min Wang, Yanjie Kuang, Jun Liu et al. · 2025 · Cell Death and Disease
82. Development of a machine learning model for predicting the expression of proteins associated with targeted therapy in endometrial cancer
    Chenwen Sun, Qianling Li, Yanan Huang, Yang Xia, M P Li, Xiucong Zhu, Jinke Zhu, Zhenhua Zhao · 2026 · Frontiers in Oncology
83. Effect of adsorbing resins on the rapamycin biosynthesis by Streptomyces hygroscopicus VKM Ac-2737D
    Вахтанг Витальевич Джавахия, Elena V. Glagoleva, Alex V. Matsyura · 2020 · Ukrainian Journal of Ecology
84. Targeting MYC to Combat Pancreatic Cancer
    Yuhong Liu, Yi‐Xiang Gan, Jun-Zong Chen, Yaxin Jiang, Fei Huang, Di Tang · 2022 · Journal of Exploratory Research in Pharmacology
85. Prostate cancer resistance leads to a global deregulation of translation factors and unconventional translation of long non-coding RNAs
    Emeline I. J. Lelong, Pauline Adjibade, France‐Hélène Joncas, Gabriel Khelifi, Valérie Grenier St-Sauveur, Amina Zoubedi, Jean‐Philippe Lambert, Paul Toren, Rachid Mazrouï, Samer M. I. Hussein · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
86. Prominin-1 (PROM1) Significantly Correlated With Bone Metastasis and Influenced Prognosis in Breast Cancer
    Yinan Wu, Chengcheng Yu, Kaimin Hu, Suzhan Zhang · 2021 · Research Square
87. Modelling Parkinson’s Disease Pre-Clinically: A Novel Virus-Fibril Inducible Mouse Model Exploring Disease Characteristics and Therapeutic Intervention via Metabotropic Glutamate Receptor 5 Negative Allosteric Modulation
    Samantha C. Bureau · 2022
88. The polyphenol/saponin-rich Rhus tripartita extract has an apoptotic effect on THP-1 cells through the PI3K/AKT/mTOR signaling pathway
    Hajer Tlili, Anca Macovei, Daniela Buonocore, Manuela Lanzafame, Hanen Najjaa, Anita Lombardi, Andrea Pagano, Maurizia Dossena, Manuela Verri, Abdelkarim Ben Arfa et al. · 2021 · Research Square
89. G6PD promotes cell proliferation and dexamethasone resistance in multiple myeloma via increasing anti-oxidant production and activatingWnt/β-catenin pathway
    Rui Li, Mengying Ke, Mingming Qi, Zhenru Han, Yuhao Cao, Zhendong Deng, Jinjun Qian, Ye Yang, Chunyan Gu · 2022 · Research Square
90. ZDHHC22-Mediated mTOR Palmitoylation Determines Breast Tumor Growth and Endocrine Therapy Sensitivity
    Jiefeng Huang, Jie Li, Jun Tang, Yushen Wu, Ziying Yi, Yan Wang, Yunhai Li, Yiqing Tan, Yue Wu, Guosheng Ren et al. · 2021 · Research Square
91. Potential prognostic value of hsa-miR-18a in hepatocellular carcinoma and the underlying key down-stream gene CHRM2: a comprehensive bioinformatic analysis*
    Zile Fu, Shuzhan Wen, Tianchang Wei, Ruiqi Gu, Shuying Chen · 2021 · Research Square
92. Molecular docking studies of biflavonoids from Selaginella doederleinii hieron as anticancer agents to inhibit mTOR
    Honesty Nurizza Pinanti, Wirdatun Nafisah, Yuyun Ika Christina, Nashi Widodo, Muhaimin Rifa’i, Muhammad Sasmito Djati · 2021 · AIP conference proceedings
93. Roles of mTOR-regulating GTPases in regulating drug resistance in senescence-like hepatoma cells
    Wei Jiang, Zhenglin Ou, Qin Zhu, Yuanbing Yao, Hongyan Zai · 2021 · Research Square
94. KRT17 Facilitates Proliferation, Migration and Invasion in Esophageal Squamous Cell Carcinoma by Regulating mTOR/S6K1 pathway
    Lei Liu, Mengqi Shao, Youyu Wang, Gang Li, Shenglong Xie, Kegang Jia, Gang Feng · 2021 · Research Square
95. Tingkat Mobilisasi Dini Pasien Pasca Laparotomi dan Seksio Sesarea dan Faktor-Faktor yang Mempengaruhinya di RSUD dr. Pirngadi Medan
    Ceriawati Bate’e · 2013
96. Genomic Signature of MTOR Could Be an Immunogenicity Marker in Human Colorectal Cancer
    Chenxing Wang, Batuer Aikemu, Yanfei Shao, Sen Zhang, Guang Yang, Hiju Hong, Ling Huang, Hongtao Jia, Xiao Yi Yang, Minhua Zheng et al. · 2022 · Research Square
97. Via mTOR e desenvolvimento ovariano
    Julia Andriotti de Castro · 2022
98. ATG5 promotes head and neck squamous cell carcinoma by regulating translation and cell cycle
    Huijuan Liu, Hui Zhang, Haidong Fan, Su Tang, Junquan Weng · 2022 · Research Square
99. Netrin-1 improves functional recovery through autophagy regulation by activating the AKT/mTOR signaling pathway in high-glucose-induced renal proximal tubule injury
    Chenxiao Liu, Mian Wu, Yun Zhao, Aijie Huang, Xingna Hu, Jiaqi Chen, Ting Lu, Min Li, Min Feng, Rong Xiang et al. · 2022 · Research Square
100. Ground Glass Appearance During the Pandemic Period: Everolimus Induced Interstitial Pneumonia
     Sidelya Ecem YİĞİT, İffet Beril GÖKMEN, Yıldız Okuturlar · 2022 · Turkish Journal of Internal Medicine